Episode Overview
This episode explores how ADHD presents and progresses in older adulthood, focusing on the distinction between age-related cognitive decline and lifelong ADHD, the role of hormones in symptom trajectories, and the current evidence around medication, monitoring, and daily life for adults over 50. The hosts examine three ADDitude features that collectively address late diagnosis, brain changes across the lifespan, and practical treatment considerations for aging adults with ADHD.
Signs of Adult ADHD? Or Old Age?
This piece profiles two people diagnosed late in life: Zophia, who spent over forty years in psychoanalysis and behavioural therapy before being diagnosed at 63 after recognising herself in a TV talk show host's ADHD description, and John Washbush, who was diagnosed at 70 and took his first dose of Ritalin on his 72nd birthday. Neither described a sudden change — both described something that had always been there and had simply never had a name.
Trajectory as the key distinction
The reporting draws a clinically meaningful line between normal cognitive aging and ADHD. Normal cognitive aging is gradual: processing speed slows from roughly the mid-thirties, and selective attention, working memory, and several executive functions decline over time. The hallmark of normal aging is that the person remembers a different baseline — "I used to manage fine; it's only recently I've been having problems." The ADHD story, by contrast, tends to be a lifelong one: daydreaming, lost homework, clutter as a way of living.
Symptom overlap and misdiagnosis
The article is careful to note that ADHD symptoms and mild cognitive impairment share significant territory: misplacing things, trouble with organisation and planning, attention problems, slowed language, and executive function difficulties. Kathleen Nadeau, founder of the Chesapeake ADHD Center of Maryland, states that memory, routine, and executive-functioning symptoms in older adults are more often interpreted as mild cognitive impairment or dementia because those are the conditions clinicians are most familiar with. She adds that ADHD looks markedly different across the lifetime, shifting at the transition from childhood to young adulthood, again at midlife, and again in the senior years.
The piece explicitly states there is no known connection between mild cognitive impairment, Alzheimer's disease, and ADHD, and leaves differential diagnosis to clinicians. ADDitude's own disclaimer notes that the material is educational, not medical advice, diagnosis, or treatment.
Child-based criteria applied to adults
Psychiatrist William Dodson argues that most symptom criteria are built on childhood presentations. He says an adult would have to be functioning at the level of a schoolchild with untreated ADHD to meet them. The underlying fact is checkable: the DSM-5 requires six impairing symptoms for people aged 17 and under, and five for adults over 17. The article notes that some researchers have suggested even fewer symptoms might suit the 40-plus population, but it does not report that any such revision has been adopted.
A wave of late diagnoses
Clinicians report steady increases in requests for testing from adults who grew up in the 1940s, 1950s, and 1960s, when ADHD was rarely recognised in children, let alone adults. The article points out that most older adults with ADHD have previously been diagnosed with something else — most often mood disorders or learning difficulties — and frames those earlier diagnoses as probably accurate but incomplete, since ADHD commonly coexists with other conditions.
Inside the Aging ADHD Brain
Hormones and symptom shifts across the lifespan
The article explains the mechanism by which oestrogen supports ADHD symptoms: oestradiol, a form of oestrogen, helps sensitise neural receptors so that dopamine and norepinephrine — the neurotransmitters involved in alertness, focus, and motivation — work more effectively. One section uses the image of oestrogen sitting on the synapse receptor like a sticky mitt, catching neurotransmitters as they jump across. When oestrogen fluctuates or drops, that support weakens.
Higher oestrogen during menstrual cycles and after conception can help suppress symptoms. At perimenopause, monthly fluctuation becomes erratic and increasingly absent. Patricia Quinn, a developmental paediatrician, reports that many women are diagnosed in their late thirties or forties at exactly that stage, and frames the clinical question as: is it ADHD, or is it menopause? The woman often says she was fine before.
Anthony Rostain describes what can happen afterward: when an ADHD brain has been operating at its upper limit and can no longer mount that extra effort, patients report feeling regressed to their pre-treatment level — the compensations that got them through simply stop working. This pairs with midlife stressors the article lists: caring for aging parents and children simultaneously, empty nests, divorce, and grief. When normal coping mechanisms stop working, neither the person nor the doctor necessarily thinks of ADHD; they think of the stressor.
Testosterone and men
For men, testosterone declines gradually with age, influencing sleep quality, mood, and cognition. The article is clear that this drop is not as precipitous as the oestrogen decline.
Quinn's clinical advice on hormone therapy
Quinn recommends that women with ADHD maintain their ADHD treatment alongside hormone therapy if they choose it. She notes that progestin at regular intervals is needed alongside oestrogen to protect against uterine cancer, and advises consulting doctors, especially with a history of vascular problems or cancer. This is Quinn's clinical recommendation, not a general rule.
Does ADHD Get Worse with Age? Persistent Symptoms and Smart Treatment in Older Adults
The treatment gap
A statistic the hosts found striking: fewer than half of adults with ADHD aged 45 and over have ever sought any kind of treatment, and only 25 percent have tried medication. The barrier is often the prescriber's caution.
Evidence gaps and off-label prescribing
David Goodman, who contributed a separate expert Q&A for ADDitude updated in 2025, is direct about the evidence gap: there are no randomised control trials of ADHD medications in people over 65. Trials enrol people without other medical conditions and without other medications, and older adults are hard to enrol for exactly that reason. Any stimulant prescription for someone over 65 is technically off-label. Goodman's overall position is not prohibition — he says it is never too late to treat ADHD with medication, and that a growing body of research indicates stimulants are relatively safe for cardiac patients and older adults.
Cardiovascular evidence
A meta-analysis published in JAMA Network Open in 2022, led by Zhang and colleagues, reviewed 19 observational studies covering approximately 3.9 million participants across the US, South Korea, Canada, Denmark, Spain, and Hong Kong. It found no statistically significant association between ADHD medications and cardiovascular disease, including among middle-aged and older adults. This is a null finding in observational data, not proof of safety in every individual.
Monitoring and practical concerns
Older adults are on more medications, and the article flags real concerns to watch for: dry mouth is serious for someone with dentures; stimulants can worsen urinary hesitancy in men with an enlarged prostate; appetite suppression can cause weight loss and complicate diabetes management, raising fall risk.
Dodson describes one practical monitoring tool some physicians use: diastolic blood pressure. He says it should not change below the optimal stimulant dose but can jump ten to fifteen points if the dose is even a few milligrams too high. This illustrates why individualised dosing and review of every prescription, including over-the-counter items like antacids, matters.
Dementia and ADHD medication
Goodman cites a 2023 study following more than 109,000 participants for seventeen years, which found that people with ADHD had a 2.77 times greater risk of dementia compared with people without ADHD, even after adjusting for factors such as obesity and diabetes. The same study found that participants treated with medication had less dementia risk than those unexposed. Goodman's conclusion is narrow: ADHD medication does not increase dementia risk, while much more research is needed to understand the link. The hosts note that an observational medication finding does not establish that treatment prevents dementia, and that association between ADHD and later dementia risk does not tell us mechanism.
Driving safety
A 2023 cohort study from Columbia's Mailman School of Public Health, published in JAMA Network Open, looked at drivers aged 65 to 79 with ADHD and reported car crashes 74 percent more likely, traffic tickets 102 percent more likely, and hard-braking events 7 percent more likely. The hosts note that the article's sentence describes the comparison group ambiguously, so it is not fully clear from the article text who the ADHD group was compared against, though the underlying citation is provided.
Practical strategies and navigating the system
The articles agree on several points for listeners wondering about themselves:
- Do not self-diagnose; see a professional. An older adult deserves the same diagnostic workup as anyone at any age — this is Rostain's line.
- A diagnosis matters practically: it is needed for medication and often for insurance coverage of testing, therapy, and behavioural support.
- If a clinician dismisses you purely on age, Goodman suggests bringing research to the appointment and seeing how they respond. He says it is easier to educate the uninformed than the misinformed. If they still will not engage, a second opinion from someone with experience in adult ADHD is reasonable. Telehealth can be an option for evaluation, though interstate prescribing rules may limit who can prescribe.
On the everyday side, strategies for ADHD later in life overlap with strategies for brain health generally: exercise, social connection to avoid isolation, intellectually stimulating puzzles and learning, and varied games in moderation. The article also mentions fish oil and vitamin D for attention, though the hosts note they would want to check these with a doctor and would want stronger evidence for supplements than for the behavioural changes.
Talk therapy for the emotional side matters too — a late diagnosis can bring shock, confusion, sadness, guilt, relief and, for older adults, regret. The article also notes coaching and cognitive behavioural therapy as practical supports for the behavioural pieces.
A fresh start rather than a verdict
Zophia's closing reflection stayed with the hosts: carrying ADHD alongside aspirations and dreams for so long is very painful, she says, but her desire to make a difference has been reawakened, and she intends to move toward her goals to her last breath.
Podcast Transcript
Aaron: Welcome to Living on the Spectrum. I'm Aaron.
Jamie: And I'm Jamie.
Aaron: Today I want to start with a scene that keeps coming up in the pieces we read. A woman named Zophia spent more than forty years in psychoanalysis and behavioural therapy, being told there was nothing wrong with her. Then in 2006 she saw a TV talk show where the host described her own ADHD, and Zophia thought, the more I heard, the more I knew she was talking about me too. A local psychologist ordered eight one-hour tests. She was diagnosed at 63.
Jamie: That's from an ADDitude feature by Linda Roggli, updated in 2026, and it profiles a second person as well. John Washbush suspected something in his early sixties, was diagnosed at 70, and took his first dose of Ritalin on his 72nd birthday. He described seventy years of living day by day in the dark, getting the same instructions as everyone else but rarely the same results.
Aaron: What struck me about both of those is that neither of them was describing a sudden change. They were describing something that had always been there and had simply never had a name. And I think that's the fork in the road for anyone listening over fifty who's wondering about themselves. Is this new, or is this old?
Jamie: That's exactly the distinction the reporting tries to draw, and it's clinically meaningful. The distinction comes down to trajectory. Normal cognitive aging is a gradual change: processing speed slows from around the mid-thirties, and selective attention, working memory and several executive functions also decline with age. But someone with normal age-related change typically remembers a different baseline. They'll say, I used to get to school on time, I turned my papers in, it's just lately I've been having problems. That story, new problems against a previously solid record, is what points a clinician toward further investigation for other causes.
Aaron: Whereas the ADHD version is, I was the daydreamer, I lost my homework often enough to exasperate my teachers, clutter was just how I lived.
Jamie: Right. And I'd add one caution, because the article is careful about it: that contrast is a clue for a professional, not a test you can run on yourself. The piece states there is no known connection between mild cognitive impairment, Alzheimer's disease and ADHD, and it explicitly leaves differential diagnosis to clinicians. ADDitude's own disclaimer says the material is educational and not medical advice, diagnosis or treatment.
Aaron: Fair, and I want to be honest about something as a listener. When I hear that ADHD symptoms and mild cognitive impairment share a lot of territory — misplacing things, trouble with organisation and planning, attention problems, slowed language, executive function trouble — I find that genuinely unsettling. The reporting says a lot of older adults with ADHD get read as mild cognitive impairment or dementia instead.
Jamie: Kathleen Nadeau makes that point directly. She's the founder of the Chesapeake ADHD Center of Maryland, and she says memory, routine and executive-functioning symptoms in older adults more often get interpreted as mild cognitive impairment or dementia, because those are the conditions clinicians are more familiar with. She also says ADHD looks markedly different across the lifetime, shifting at the transition from childhood to young adulthood, again at midlife, and again in the senior years.
Aaron: And there's a structural reason too, isn't there? One of the psychiatrists quoted, William Dodson, argues that most symptom criteria are child-based. He says an adult would have to be functioning at the level of a schoolchild with untreated ADHD to meet them.
Jamie: He does say that. And the underlying fact is checkable: the DSM-5 requires six impairing symptoms for people aged 17 and under, and five for adults over 17. The article notes that some researchers have suggested even fewer symptoms might suit the 40-plus population, but it does not report that any such revision has been adopted. So we're talking about criteria built largely on childhood presentations being applied to people in their sixties and seventies.
Aaron: Which helps explain why there's a wave of people in their sixties and seventies now asking for testing. The clinicians report steady increases in requests from adults who grew up in the forties, fifties and sixties, when ADHD was rarely recognised in children, let alone adults.
Jamie: And the article points out that most older adults with ADHD have previously been diagnosed with something else, most often mood disorders or learning difficulties. The framing is that those earlier diagnoses were probably accurate but incomplete, since ADHD commonly coexists with other conditions.
Aaron: Okay, I want to pivot to something that surprised me, which is hormones. Because for a long time I thought of ADHD recognition in women as a thirties-and-forties story.
Jamie: It often is, and the mechanism is worth understanding because it's not mystical. Oestradiol, a form of oestrogen, helps sensitise neural receptors so that dopamine and norepinephrine — the neurotransmitters involved in alertness, focus and motivation — work more effectively. When oestrogen fluctuates or drops, that support weakens. One article uses a nice image for oestrogen sitting on the synapse receptor like a sticky mitt catching neurotransmitters as they jump across.
Aaron: So the monthly cycle can actually mask or unmask symptoms.
Jamie: The reporting says higher oestrogen during cycles and after conception can help suppress symptoms. Then at perimenopause the monthly fluctuation becomes erratic and increasingly absent, and Patricia Quinn, a developmental paediatrician, reports that many women are diagnosed in their late thirties or forties at exactly that stage. Her framing of the clinical question is: is it ADHD or is it menopause? Because the woman says she was fine before.
Aaron: And Rostain's description of what happens afterwards felt very human to me. He says that when an ADHD brain has been operating at its upper limit and can no longer mount that extra effort, patients report feeling regressed to their pre-treatment level. Like the compensations that got you through just stopped working.
Jamie: Which pairs with the midlife stressors the first article lists — caring for aging parents and children at the same time, an empty nest, divorce, grief. When normal coping mechanisms stop working, neither the person nor the doctor necessarily thinks of ADHD. They think of the stressor.
Aaron: For men it's gentler but present. Testosterone declines gradually with age, influencing sleep quality, mood and cognition, though the article is clear that this drop is not as precipitous as the oestrogen decline.
Jamie: That's the article's characterisation, yes. And Quinn's clinical advice in the piece is that women with ADHD should maintain their ADHD treatment alongside hormone therapy if they choose it, and that progestin at regular intervals is needed alongside oestrogen to protect against uterine cancer. She also recommends women consult their doctors, especially with a history of vascular problems or cancer. That's her recommendation, not a general rule.
Aaron: Let's talk medication, because this is where a lot of listeners will be holding their breath. There's a statistic that stopped me: fewer than half of adults with ADHD aged 45 and over have ever sought any kind of treatment, and only 25 percent have tried medication.
Jamie: And the barrier is often the prescriber's caution. David Goodman, who wrote a separate expert Q&A for ADDitude updated in 2025, is direct about the evidence gap. There are no randomised control trials of ADHD medications in people over 65. Trials enrol people without other medical conditions and without other medications, and older adults are hard to enrol for exactly that reason. So any stimulant prescription for someone over 65 is technically off-label.
Aaron: Which sounds alarming, but Goodman's overall position isn't prohibition. He says it's never too late to treat ADHD with medication, and that a growing body of research indicates stimulants are relatively safe for cardiac patients and older adults.
Jamie: And there is a specific meta-analysis supporting the cardiovascular side. It was published in JAMA Network Open in 2022, led by Zhang and colleagues, a systematic review and meta-analysis of 19 observational studies covering about 3.9 million participants across the US, South Korea, Canada, Denmark, Spain and Hong Kong. It found no statistically significant association between ADHD medications and cardiovascular disease, including among middle-aged and older adults. That's a null finding in observational data, not proof of safety in every individual.
Aaron: And the monitoring point matters as much as the reassurance. Older adults are on more medications, and the article flags real concerns to watch for: dry mouth is serious for someone with dentures, stimulants can worsen urinary hesitancy in men with an enlarged prostate, appetite suppression can cause weight loss and complicate diabetes management, which raises fall risk.
Jamie: Dodson describes one practical monitoring tool some physicians use, which is blood pressure — specifically the diastolic reading, the bottom number in a reading. He says it should not change below the optimal stimulant dose, but can jump ten to fifteen points if the dose is even a few milligrams too high. That's his clinical description, and it's a good illustration of why individualised dosing and review of every prescription, including over-the-counter items like antacids, matters.
Aaron: There's also the dementia question, and I want to handle this carefully because I know correlation isn't causation.
Jamie: Please do, because the framing is easy to get wrong. Goodman cites a 2023 study following more than 109,000 participants for seventeen years, which found that compared with people without ADHD, those with ADHD had a 2.77 times greater risk of dementia, even after adjusting for factors like obesity and diabetes. The same study found participants treated with medication had less dementia risk than those unexposed to medication. Goodman's conclusion is narrow: ADHD medication does not increase dementia risk, while much more research is needed to understand the link. That second clause is doing real work.
Aaron: Right, so the takeaway is reassurance about medication, not alarm about dementia.
Jamie: Exactly. And I'd add that association between ADHD and later dementia risk doesn't tell us mechanism, and an observational medication finding doesn't establish that treatment prevents dementia.
Aaron: One more study I found useful, because it's about daily life rather than chemistry. A 2023 cohort study from Columbia's Mailman School of Public Health, published in JAMA Network Open, looked at drivers aged 65 to 79 with ADHD and reported car crashes 74 percent more likely, traffic tickets 102 percent more likely, and hard-braking events 7 percent more likely.
Jamie: And here's a detail I want to name because it's a good habit: the article's sentence describes the comparison group ambiguously, so we can't be fully certain from the article text who the 65-to-79 group with ADHD was being compared against. The underlying citation is there, but the wording is imprecise. I'd rather flag that than smooth it over.
Aaron: That's fair, and honestly it's one of the reasons I trust the rest of this reporting more. So where does this leave someone listening who's in their fifties or sixties, wondering?
Jamie: A few things the articles agree on. First, don't self-diagnose; see a professional, and an older adult deserves the same diagnostic workup as anyone at any age — that's Rostain's line. Second, a diagnosis matters practically, because it's needed for medication and often for insurance coverage of testing, therapy and behavioural support. Third, if a clinician dismisses you purely on age, Goodman suggests bringing research to the appointment and seeing how they respond. He says it's easier to educate the uninformed than the misinformed. If they still won't engage, a second opinion from someone with experience in adult ADHD is reasonable, and telehealth can be an option for evaluation, though interstate prescribing rules may limit who can prescribe.
Aaron: And on the everyday side, the strategies for ADHD later in life overlap a lot with strategies for brain health generally: exercise, social connection to avoid isolation, intellectually stimulating puzzles and learning, varied games in moderation. The article also mentions fish oil and vitamin D for attention, though I'd want to check those with a doctor before assuming much.
Jamie: That's sensible. Supplements can interact with other medications, and I'd want stronger evidence for them than I'd want for the behavioural changes. And I'd note talk therapy for the emotional side — a late diagnosis can bring shock, confusion, sadness, guilt, relief and, for older adults, regret. The article also notes coaching and cognitive behavioural therapy as practical supports for the behavioural pieces.
Aaron: Zophia's last line stayed with me. Carrying ADHD alongside aspirations and dreams for so long is very painful, she says, but her desire to make a difference has been reawakened, and she intends to move toward her goals to her last breath. Diagnosis as a fresh start rather than a verdict.
Jamie: Which is a fair place to land. Age shouldn't be a deterrent to evaluation, and it's also not a guarantee of anything. Individual circumstances, other health conditions and a clinician's judgement all still apply.
Aaron: That's our episode for today. If any of this resonated, the episode page has summaries of all the articles we discussed plus links to the originals.
Jamie: Thanks for listening. Take care of yourselves, and we'll see you next time.